Chenghe Wang
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Circular RNAs in diseases
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- RNA Research and Splicing
Papers in
-
- MicroRNA in disease regulation 10
- Cancer-related molecular mechanisms research 10
- Cancer, Hypoxia, and Metabolism 6
- Cancer, Lipids, and Metabolism 4
-
- RNA modifications and cancer 9
- Epigenetics and DNA Methylation 5
- Co-authors
- Yu Zhu (8 shared papers)Zhangqun Ye (9 shared papers)Wen Jiang (4 shared papers)Zhong Chen (9 shared papers)Qingsong Zhang (6 shared papers)Jia Hu (6 shared papers)Dandan Zhu (2 shared papers)Chuanchang Li (4 shared papers)
- Journals
- Oncology Reports (3 papers)Cancer Medicine (2 papers)Tumor Biology (2 papers)Frontiers in Oncology (2 papers)Aging (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Chenghe Wang
35 papers receiving 491 citations
Peers
Comparison fields: 5 of 65
- Cancer Research 282
- Molecular Biology 332
- Oncology 76
- Pulmonary and Respiratory Medicine 80
- Surgery 93
Countries citing papers authored by Chenghe Wang
This map shows the geographic impact of Chenghe Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenghe Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenghe Wang more than expected).
Fields of papers citing papers by Chenghe Wang
This network shows the impact of papers produced by Chenghe Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenghe Wang. The network helps show where Chenghe Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Chenghe Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 53 | |
| 2 | 2016 | 50 | |
| 3 | 2020 | 49 | |
| 4 | 2017 | 36 | |
| 5 | 2020 | 32 | |
| 6 | 2015 | 32 | |
| 7 | 2019 | 29 | |
| 8 | 2016 | 29 | |
| 9 | 2021 | 24 | |
| 10 | Clinicopathologic and prognostic significance of p21 (Cip1/Waf1) expression in bladder cancer. | 2015 | 22 |
| 11 | 2017 | 14 | |
| 12 | 2015 | 11 | |
| 13 | 2017 | 11 | |
| 14 | 2023 | 10 | |
| 15 | 2017 | 10 | |
| 16 | HSP70 inhibitor VER155008 suppresses pheochromocytoma cell and xenograft growth by inhibition of PI3K/AKT/mTOR and MEK/ERK pathways. | 2019 | 10 |
| 17 | 2016 | 8 | |
| 18 | 2015 | 8 | |
| 19 | 2017 | 7 | |
| 20 | Up-regulation of E-cadherin by saRNA inhibits the migration and invasion of renal carcinoma cells. | 2018 | 7 |
About Chenghe Wang
Chenghe Wang is a scholar working on Cancer Research, Molecular Biology, Surgery, Pulmonary and Respiratory Medicine and Oncology, having authored 39 papers that have together received 495 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (10 papers), Cancer-related molecular mechanisms research (10 papers), RNA modifications and cancer (9 papers), Ferroptosis and cancer prognosis (6 papers), Cancer, Hypoxia, and Metabolism (6 papers), Bladder and Urothelial Cancer Treatments (5 papers), Epigenetics and DNA Methylation (5 papers) and Cancer, Lipids, and Metabolism (4 papers). The work is most often cited by research in Cancer Research (282 citations), Molecular Biology (332 citations), Oncology (76 citations), Pulmonary and Respiratory Medicine (80 citations) and Surgery (93 citations). Chenghe Wang has collaborated with scholars based in China and United States. Frequent co-authors include Yu Zhu, Zhangqun Ye, Wen Jiang, Zhong Chen, Qingsong Zhang, Jia Hu, Dandan Zhu, Chuanchang Li, Zhong Chen and Kai Cui. Their work appears in journals such as Oncology Reports, Cancer Medicine, Tumor Biology, Frontiers in Oncology and Aging.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.